3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
4
Melanoma
2
Uterine Cervical Neoplasms
1
Solid Tumor, Adult
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neuromyelitis Optica
1
Neoplasms, Second Primary
1
Neoplasm Metastasis
1
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
1
Myasthenia Gravis
1
Multiple Sclerosis
1
Lung Neoplasms
1
Laryngectomy; Status
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Endometrial Neoplasms
1
Encephalomyelitis, Acute Disseminated
1
Carcinoma, Renal Cell
1
COVID-19
1
Breast Neoplasms
1
Autoimmune Diseases of the Nervous System
1
Interventions
Pyridostigmine Bromide
4
Tacrolimus
2
Prednisone
2
Mycophenolic Acid
2
tocilizumab
1
sargramostim
1
Thymectomy
1
Tablets
1
Steroids
1
Sternotomy
1
Rituximab
1
Methylprednisolone
1
Methotrexate
1
Immunosuppressive Agents
1
Immunoglobulins, Intravenous
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Exercise
1
Data Collection
1
Cyclosporine
1
Cyclophosphamide
1
Azathioprine
1
Amifampridine
1
Alkalies
1
Albuterol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Myasthenia Gravis
×
Data Collection
×
Clear all
NCT06443333
2024-06-05
NIDBase
Xuanwu Hospital, Beijing
Unknown
7,000 enrolled